Taysha Gene Therapies, Inc. TSHA Change In Fair Value Of Warrant Liability
Change In Fair Value Of Warrant Liability at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept tsha:ChangeInFairValueOfWarrantLiability.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s change in fair value of warrant liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s change in fair value of warrant liability?
- Taysha Gene Therapies, Inc. (TSHA) reported change in fair value of warrant liability of $0 in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s change in fair value of warrant liability changed year-over-year?
- Taysha Gene Therapies, Inc.'s change in fair value of warrant liability increased by 100.0% year-over-year, from -$102K to $0.
- What does change in fair value of warrant liability mean?
- This metric represents the non-cash gain or loss resulting from the periodic revaluation of outstanding warrants classified as liabilities. As the fair value of these financial instruments fluctuates based on changes in the company's stock price and volatility, the resulting adjustment is recognized in the income statement. It reflects the impact of market-driven valuation changes on the company's financial position rather than core operational performance.